| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/15/2010 | CN101830876A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine |
| 09/15/2010 | CN101829248A Traditional Chinese medicine for treating goiter |
| 09/15/2010 | CN101829228A Method for extracting digitonin |
| 09/15/2010 | CN101185727B Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
| 09/15/2010 | CN101129310B Anti-dandruff shampoo of common camellia seed |
| 09/14/2010 | US7795280 3-(2-Nitro-phenylsulfanyl)-1-pyridin-2-ylmethyl-1H-indole-6-carbonitrile, used for the treatment of benign prostate hyperplasia, bone disorders, female sexual dysfunction,, atherosclerosis, anemia, muscular atrophy, as contraceptives or for hormone replacement therapy |
| 09/14/2010 | US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia |
| 09/14/2010 | US7795204 supplementing the diet of an athlete with substances which increase the concentration of nitric oxide (NO) or increase its half life in the body, in combination with a source of amino acids, may provide surprising enhancement of an athlete's muscle |
| 09/14/2010 | CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase |
| 09/14/2010 | CA2401757C Novel fatty acid analogues |
| 09/14/2010 | CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth |
| 09/10/2010 | WO2010101949A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 09/10/2010 | WO2010101127A1 Indole compound |
| 09/10/2010 | CA2754058A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 09/10/2010 | CA2753991A1 Secreted ap2 and methods of inhibiting same |
| 09/09/2010 | US20100227806 Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment |
| 09/09/2010 | US20100226966 Method for transdermal controlled release drug delivery |
| 09/09/2010 | US20100226954 Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/08/2010 | EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii |
| 09/08/2010 | EP2226315A1 2-aminoquinazoline derivative |
| 09/08/2010 | EP2225257A2 Preparation of 6-oxa-8alpha-steroid estrogen analogues - a new group of unnatural estrogens and their use in medicine |
| 09/08/2010 | EP2225256A2 Novel glucocorticoid receptor agonists |
| 09/08/2010 | EP2224945A1 Methods of enhancing diabetes resolution |
| 09/08/2010 | EP2007770B1 Imidazo compounds |
| 09/08/2010 | EP1919878B1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 09/08/2010 | EP1572230B1 Placental alkaline phosphatase to control diabetes |
| 09/08/2010 | EP1478624B1 Chemical compounds |
| 09/08/2010 | CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/08/2010 | CN101827840A Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 09/08/2010 | CN101827595A Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor |
| 09/08/2010 | CN101824036A Salt of tetrahydroimidazo [1,5-a] pyrazine derivative, preparation method and pharmaceutical application thereof |
| 09/08/2010 | CN101823976A Novel L-tyrosine production device |
| 09/08/2010 | CN101823975A Method for industrially producing L-tyrosine by using poultry feather as raw materials |
| 09/08/2010 | CN101822662A Application of 9,10-dioxystearic acid (DHSA) in preparing medicaments for preventing and treating diabetes |
| 09/08/2010 | CN101014329B Pharmaceutical composition for preventing or treating rejection reaction of organ or tissue transplant, host resistance reaction of implant in bone marrow transplantation |
| 09/07/2010 | US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases |
| 09/07/2010 | CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/07/2010 | CA2226177C Analogs of parathyroid hormone |
| 09/02/2010 | WO2010097576A1 1, 4-disubstituted piperidines as vasopressin receptor via antagonists |
| 09/02/2010 | US20100222386 Substituted piperidines |
| 09/02/2010 | US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| 09/02/2010 | US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 09/02/2010 | US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/02/2010 | US20100221445 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof |
| 09/02/2010 | US20100221305 Formulations for coated microprojections containing non-volatile counterions |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2222653A1 Novel 4,5-dihydroisoxazoles with estrogenic activity |
| 09/01/2010 | EP2222636A2 Selective androgen receptor modulators (sarms) and uses thereof |
| 09/01/2010 | CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 09/01/2010 | CN101821271A 6-substituted sulfonyl azabicyclo 3.2.1''octanes useful to inhibit 11 -hydroxysteroid dehydrogenase type-1 |
| 09/01/2010 | CN101821265A Substituted bicyclic piperidinyl-and piperazinyl- sulfonamides useful to inhibit 11ss-hydroxysteroid dehydrogenase type-1 |
| 09/01/2010 | CN101821235A Pyrrolidin-2 -one derivatives as androgen receptor modulator |
| 09/01/2010 | CN101816662A Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/26/2010 | WO2010095425A1 Method for producing crystals of vitamin d derivative |
| 08/26/2010 | WO2010094821A1 Use of vaginally-administered insulin sensitizing agents |
| 08/26/2010 | WO2010049678A3 Treatment of energy utilization diseases |
| 08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
| 08/26/2010 | US20100216758 Pyridone Compounds |
| 08/26/2010 | US20100216729 Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts |
| 08/26/2010 | US20100216728 New use of specific cyklolignans |
| 08/26/2010 | US20100216693 Compositions and methods of treating diabetes |
| 08/26/2010 | US20100215614 Enterostatin as Inhibitor of Angiogenesis |
| 08/25/2010 | EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 08/25/2010 | EP2219607A1 Lh liquid formulations |
| 08/25/2010 | EP1742912B1 Novel androgens |
| 08/25/2010 | EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 08/25/2010 | EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 08/25/2010 | EP1263722B1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof |
| 08/25/2010 | EP1263721B1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 08/25/2010 | CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 08/25/2010 | CN101815535A molecules for targeting compounds to various selected organs or tissues |
| 08/25/2010 | CN101810806A Medicament for treating hyperprolactinemia and preparation method thereof |
| 08/24/2010 | US7781647 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 08/24/2010 | CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/24/2010 | CA2467857C Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/24/2010 | CA2348493C Textured and porous silicone rubber |
| 08/19/2010 | WO2010092440A1 Cxcr2 receptor antagonists for the treatment or the prevention of insulin resistance |
| 08/19/2010 | WO2010091637A1 Antibodies and methods for treating estrogen receptor-associated diseases |
| 08/19/2010 | WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 08/19/2010 | US20100210716 Process for Preparing an Alpha-Lipoic Acid/Cyclodextrin Complex and Product Prepared |
| 08/19/2010 | US20100210706 Pyrrolidinone anilines as progesterone receptor modulators |
| 08/19/2010 | US20100210685 Novel Substituted Indoles |
| 08/19/2010 | US20100210678 Tricyclic androgen receptor modulator compounds and methods |
| 08/19/2010 | US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors |
| 08/19/2010 | US20100210613 Transdermally Absorbable Preparation |
| 08/19/2010 | US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/19/2010 | US20100209529 Pharmacologic-functioning water and usage of the same |
| 08/19/2010 | US20100209520 Oral pharmaceutical preparation for colon-specific delivery |
| 08/19/2010 | US20100209442 Deglycosylated and desialidated long pentraxin ptx3 |
| 08/19/2010 | US20100209384 Sustained release formulations comprising very low molecular weight polymers |
| 08/19/2010 | DE102009007771A1 Bukkales Applikationssystem, 17α-Estradiol enthaltend Buccal delivery system, 17α-estradiol containing |
| 08/18/2010 | EP2066677B1 Pyridooxazepine progesteron receptor modulators |
| 08/18/2010 | CN1795193B N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 08/18/2010 | CN1717243B Papaya puree and the use of the same |